Subcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis

Subcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; p. viii103
Main Authors: Kümmel, S., Tondini, C.A., Abraham, J., Nowecki, Z.I., Itrych, B., Hitre, E., Karaszewska, B., Juarez, A., Morales-Vásquez, F., Pérez García, J.M., Cardona-Huerta, S., Heinzmann, D., He, J., Duc, A.N., Crepelle-Fléchais, A., Martín, M.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy272.313